Ministry of Health in Malawi: Strengthening Laboratory Services for HIV Care PEPFAR Grant

Government Organizations:
• National Ministries of Health
• State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) .
• American Indian/Alaska Native tribal governments (federally recognized or state-recognized)
• Political subdivisions of States (in consultation with States)

Non-government Organizations:
• American Indian/Alaska native tribally designated organizations
• Alaska Native health corporations
• Tribal epidemiology centers
• Urban Indian health organizations
• Nonprofit with 501C3 IRS status (other than institution of higher education)
• Nonprofit without 501C3 IRS status (other than institution of higher education)
• Research institutions (that will perform activities deemed as non-research)

Colleges and Universities

Community-based organizations

Faith-based organizations

For-profit organizations (other than small business)

Hospitals

Small, minority, and women-owned businesses

All Other eligible organizations

The activities of the program will include health systems strengthening by increasing human resources, implementing necessary alterations and refurbishment to physical infrastructure, improving the specimen referral system, and improving data generation and handling capabilities through an electronic information system.

The program will support the Ministry of Health (MOH) of Malawi to update the National Laboratory Policy document and the national laboratory strategic plan (NLSP) as well as other guidelines that standardize the delivery of laboratory services in Malawi. The program will support the National HIV response in prevention, diagnosis, eligibility determination, and monitoring of treatment effectiveness. Activities will therefore improve scaling up of early infant diagnosis (EID), CD4 monitoring, viral load monitoring, hematology, and chemistry, as well as improving diagnosis of opportunistic infections (OIs).